ProUroCare Medical

ProUroCare Medical Revenue per Share

Revenue per Share of ProUroCare Medical (PUMD) as of Oct 29, 2026.

Revenue per Share

0.00USD

Last updated:

Revenue per Share of ProUroCare Medical is 2012 0.00 USD. Revenue per Share of ProUroCare Medical was 2011 - USD. It decreases by % lower compared to the previous year.

The ProUroCare Medical Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2006
0.00 USD
Jan 1, 2007
0.00 USD
Jan 1, 2008
0.00 USD
Jan 1, 2009
0.00 USD
Jan 1, 2010
0.00 USD
Jan 1, 2011
0.00 USD
Jan 1, 2012
0.00 USD
The ProUroCare Medical Revenue per Share history
YEARRevenue per ShareYoY
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ProUroCare Medical Stock analysis

What does ProUroCare Medical do? ProUroCare Medical Inc develops the ProUroScan System, a prostate mechanical imaging device for detecting and characterizing male prostate disease. The system uses sensors on a rectal probe, a central processing unit, and software to generate real-time color images of prostate abnormalities detected via digital rectal examination. It provides elasticity imaging, offering non-invasive tissue analysis, and delivers two- and three-dimensional prostate images. The company sells this medical device directly to healthcare providers for diagnostic use. The ProUroScan System is marketed as an adjunctive aid for visualizing prostate abnormalities identified during digital rectal exams. Healthcare providers, including urologists and specialists in prostate health, purchase the device to enhance diagnostic capabilities. The product targets medical facilities requiring advanced imaging solutions for prostate disease detection and characterization. ProUroCare focuses exclusively on the ProUroScan System, with no other products mentioned in the business description. The company’s revenue comes solely from the sale of this imaging system to healthcare professionals and institutions. The device is positioned as a tool for improving diagnostic accuracy in prostate examinations. ProUroCare Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ProUroCare Medical stock

On Eulerpool you can find the complete historical development of Revenue per Share ProUroCare Medical since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — ProUroCare Medical

All Key Metrics — ProUroCare Medical